# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015972
Filing Date
2022-04-26
Accepted
2022-04-26 16:41:38
Documents
9
Period of Report
2022-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20003107x1_def14a.htm | DEF 14A | 1573609
2 |  | ny20003107x1_barchart01.jpg | GRAPHIC | 132904
3 |  | ny20003107x1_barchart02.jpg | GRAPHIC | 195693
4 |  | ny20003107x1_pc1x1.jpg | GRAPHIC | 710143
5 |  | ny20003107x1_pc2x1.jpg | GRAPHIC | 683363
6 |  | ny20003107x1_piechart01.jpg | GRAPHIC | 169351
7 |  | ny20003107x1_piechart02.jpg | GRAPHIC | 113603
8 |  | ny20003107x1_piechart03.jpg | GRAPHIC | 144733
9 |  | ny20003107x1_piechart04.jpg | GRAPHIC | 84941
| Complete submission text file | 0001140361-22-015972.txt |  | 4650836

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 22854941
SIC: 2836 Biological Products, (No Diagnostic Substances)